Martingale Asset Management L P Pfizer Inc Transaction History

Martingale Asset Management L P

$4.27 Billion
Q3 2024

A detailed history of Martingale Asset Management L P transactions in Pfizer Inc stock. As of the latest transaction made, Martingale Asset Management L P holds 24,608 shares of PFE stock, worth $648,666. This represents 0.02% of its overall portfolio holdings.

Number of Shares

24,608

Previous 24,593 0.06%

Holding current value

$648,666

Previous $688,000 3.49%

% of portfolio

0.02%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $415 - $470	15 Added 0.06%	24,608 $712,000
Q2 2024 Aug 12, 2024	BUY	$25.26 - $29.6 $75 - $88	3 Added 0.01%	24,593 $688,000
Q1 2024 May 14, 2024	SELL	$25.89 - $29.73 $5.71 Million - $6.56 Million	-220,650 Reduced 89.97%	24,590 $682,000
Q4 2023 Feb 12, 2024	SELL	$26.13 - $33.94 $24.1 Million - $31.4 Million	-923,998 Reduced 79.03%	245,240 $7.06 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $2.13 Million - $2.49 Million	-66,335 Reduced 5.37%	1,169,238 $38.8 Million
Q2 2023 Aug 11, 2023	SELL	$36.12 - $41.79 $502,429 - $581,298	-13,910 Reduced 1.11%	1,235,573 $45.3 Million
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $1.48 Million - $1.93 Million	37,563 Added 3.1%	1,249,483 $51 Million
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $3.21 Million - $4.19 Million	-76,827 Reduced 5.96%	1,211,920 $62.1 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $983,812 - $1.2 Million	22,482 Added 1.78%	1,288,747 $56.4 Million
Q2 2022 Aug 11, 2022	SELL	$46.53 - $55.17 $3.02 Million - $3.58 Million	-64,977 Reduced 4.88%	1,266,265 $66.4 Million
Q1 2022 May 12, 2022	SELL	$45.75 - $56.69 $6.8 Million - $8.42 Million	-148,558 Reduced 10.04%	1,331,242 $68.9 Million
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $4.63 Million - $6.87 Million	112,107 Added 8.2%	1,479,800 $87.4 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $3.78 Million - $4.86 Million	-96,294 Reduced 6.58%	1,367,693 $58.8 Million
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $19.7 Million - $22.3 Million	-547,724 Reduced 27.23%	1,463,987 $57.3 Million
Q1 2021 May 13, 2021	SELL	$33.49 - $37.77 $7.65 Million - $8.63 Million	-228,368 Reduced 10.19%	2,011,711 $72.9 Million
Q4 2020 Feb 10, 2021	BUY	$33.47 - $42.56 $8.7 Million - $11.1 Million	260,040 Added 13.13%	2,240,079 $82.5 Million
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $1.01 Million - $1.19 Million	-31,912 Reduced 1.59%	1,980,039 $68.9 Million
Q2 2020 Aug 10, 2020	BUY	$30.12 - $36.54 $5.15 Million - $6.25 Million	170,975 Added 9.29%	2,011,951 $62.4 Million
Q1 2020 May 11, 2020	BUY	$27.03 - $38.62 $12.1 Million - $17.3 Million	448,685 Added 32.23%	1,840,976 $57 Million
Q4 2019 Feb 10, 2020	BUY	$32.92 - $37.36 $224,053 - $254,272	6,806 Added 0.49%	1,392,291 $51.8 Million
Q3 2019 Nov 13, 2019	SELL	$32.49 - $42.13 $7.8 Million - $10.1 Million	-239,920 Reduced 14.76%	1,385,485 $47.2 Million
Q2 2019 Aug 13, 2019	SELL	$36.98 - $41.52 $3.16 Million - $3.55 Million	-85,463 Reduced 5.0%	1,625,405 $0
Q1 2019 May 08, 2019	BUY	$37.5 - $41.2 $2.58 Million - $2.83 Million	68,674 Added 4.18%	1,710,868 $0
Q4 2018 Feb 11, 2019	SELL	$38.47 - $43.86 $4.12 Million - $4.7 Million	-107,208 Reduced 6.13%	1,642,194 $68 Million
Q3 2018 Nov 09, 2018	BUY	$34.47 - $41.81 $1.36 Million - $1.65 Million	39,464 Added 2.31%	1,749,402 $0
Q2 2018 Aug 09, 2018	BUY	$32.98 - $35.16 $533,451 - $568,713	16,175 Added 0.95%	1,709,938 $0
Q1 2018 May 11, 2018	BUY	$31.91 - $37.02 $14.5 Million - $16.8 Million	453,596 Added 36.58%	1,693,763 $0
Q4 2017 Feb 12, 2018	BUY	$33.26 - $35.29 $3.38 Million - $3.58 Million	101,560 Added 8.92%	1,240,167 $0
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $35.3 Million - $38.9 Million	1,138,607	1,138,607 $40.6 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.

Account

Martingale Asset Management L P Pfizer Inc Transaction History